GalNAc-T14 may Contribute to Production of Galactose-Deficient Immunoglobulin A1, the Main Autoantigen in IgA Nephropathy

Introduction Immunoglobulin A1 (IgA1) with galactose-deficient O-glycans (Gd-IgA1) play a key role in the pathogenesis of IgA nephropathy (IgAN). Mucosal-tissue infections increase IL-6 production and, in patients with IgAN, are often associated with macroscopic hematuria. IgA1-secreting cell lines derived from the circulation of patients with IgAN, compared to those of healthy controls (HCs), produce more IgA1 that has O-glycans with terminal or sialylated N-acetylgalactosamine (GalNAc). GalNAc residues are added to IgA1 hinge region by some of the 20 GalNAc transferases, the O-glycosylation-initiating enzymes. Expression of GALNT2, encoding GalNAc-T2, the main enzyme initiating IgA1 O-glycosylation, is similar in cells derived from patients with IgAN and HCs. In this report, we extend our observations of GALNT14 overexpression in IgA1-producing cell lines from patients with IgAN. Methods GALNT14 expression was analyzed in peripheral blood mononuclear cells (PBMCs) from patients with IgAN and from HCs. Moreover, the effect of GALNT14 overexpression or knock-down on Gd-IgA1 production in Dakiki cells was assessed. Results GALNT14 was overexpressed in PBMCs from patients with IgAN. IL-6 increased GALNT14 expression in PBMCs from patients with IgAN and HCs. We used IgA1-producing cell line Dakiki, a previously reported model of Gd-IgA1-producing cells, and showed that overexpression of GalNAc-T14 enhanced galactose deficiency of IgA1, whereas siRNA-mediated GalNAc-T14 knock-down reduced it. GalNAc-T14 was localized in trans-Golgi network, as expected. Conclusions Overexpression of GALNT14 due to inflammatory signals during mucosal infections may contribute to overproduction of Gd-IgA1 in patients with IgAN.

• Publication year

  2023

• Venue

  Kidney International Reports

• Publication date

  2023-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ekir.2023.02.1072PMID 37180502PMCID 10166743
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors

  2022influential reference
• O-glycoforms of polymeric IgA1 in the plasma of patients with IgA nephropathy are associated with pathological phenotypes.

  2021cited by this paper
• Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know

  2021cited by this paper
• Quantitative assessment of successive carbohydrate additions to the clustered O -glycosylation sites of IgA1 by glycosyltransferases

  2021influential reference
• LC-MS methods analyzing clustered O-glycosylation reactions.

  2020cited by this paper
• IgA nephropathy.

  2020influential reference
• GALNT14: An Emerging Marker Capable of Predicting Therapeutic Outcomes in Multiple Cancers

  2020cited by this paper
• Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy

  2020cited by this paper
• IgA1 hinge-region clustered glycan fidelity is established early during semi-ordered glycosylation by GalNAc-T2.

  2019cited by this paper
• Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.

  2019cited by this paper
• Evaluation of IgA1 O-glycosylation in Henoch-Schönlein Purpura Nephritis Using Mass Spectrometry.

  2019cited by this paper
• Insights into Structural and Mechanistic Features of Viral IRES Elements

  2018cited by this paper
• Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy

  2017cited by this paper
• IgA nephropathy enigma.

  2016cited by this paper
• IgA nephropathy

  2016cited by this paper
• The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy

  2016cited by this paper
• Heterogeneity of Aberrant O-Glycosylation of IgA1 in IgA Nephropathy

  2016cited by this paper
• N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy.

  2015cited by this paper
• Specificity of two monoclonal antibodies against a synthetic glycopeptide, an analogue to the hypo-galactosylated IgA1 hinge region

  2014cited by this paper
• Enzymatic Sialylation of IgA1 O-Glycans: Implications for Studies of IgA Nephropathy

  2014cited by this paper
• Cytokines Alter IgA1 O-Glycosylation by Dysregulating C1GalT1 and ST6GalNAc-II Enzymes

  2013cited by this paper
• IgA nephropathy: molecular mechanisms of the disease.

  2013cited by this paper
• Production of N-acetylgalactosaminyl-transferase 2 (GalNAc-T2) fused with secretory signal Igκ in insect cells.

  2012cited by this paper
• Naturally occurring structural isomers in serum IgA1 o-glycosylation.

  2012cited by this paper
• Glycosylation of IgA1 and pathogenesis of IgA nephropathy

  2012influential reference
• Deficiency of N‐acetylgalactosamine in O‐linked oligosaccharides of IgA is a novel biologic marker for Crohn's disease

  2012cited by this paper
• The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression

  2012influential reference
• Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy.

  2012influential reference
• Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis.

  2011cited by this paper
• Glycosylation Patterns of HIV-1 gp120 Depend on the Type of Expressing Cells and Affect Antibody Recognition

  2010cited by this paper
• Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes

  2010cited by this paper
• A new equation to estimate glomerular filtration rate.

  2009cited by this paper
• Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.

  2009cited by this paper
• IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.

  2008influential reference
• Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy.

  2008cited by this paper
• Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.

  2007cited by this paper
• Identification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cells.

  2007cited by this paper
• IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.

  2007cited by this paper
• The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation.

  2007cited by this paper
• Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties

  2005cited by this paper
• CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells.

  2003cited by this paper
• Initiation of O-Glycan Synthesis in IgA1 Hinge Region Is Determined by a Single Enzyme, UDP-N-Acetyl-α-d-galactosamine:PolypeptideN-Acetylgalactosaminyltransferase 2*

  2003cited by this paper
• Cloning and characterization of a novel UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase, pp-GalNAc-T14.

  2003cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry.

  2000cited by this paper
• Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.

  1999cited by this paper
• Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

  1998cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• GALNT14 deficiency: connecting multiple links in the IgA nephropathy pathogenetic chain

  2025cites this paper
• Glaucumolides C-P, cembrane-type diterpenoids from the marine soft coral Sarcophyton glaucum with potential attenuating activities against IgAN nephropathy

  2025cites this paper
• Immunoglobulin A Nephropathy: Molecular Pathogenesis and Targeted Therapy

  2025cites this paper
• Emerging Biochemical and Immunologic Mechanisms in the Pathogenesis of IgA Nephropathy.

  2025cites this paper
• The evolving understanding of systemic mechanisms in organ-specific IgA nephropathy: a focus on gut-kidney crosstalk

  2025cites this paper
• Loss of GalNAc-T14 links O-glycosylation defects to alterations in B cell homing in IgA nephropathy

  2024cites this paper
• Pathogenesis of IgA nephropathy: Omics data inform glycomedicine

  2024cites this paper
• Polypeptide N-Acetylgalactosaminyl transferase 14 is a novel mediator in pancreatic β-cell function and growth.

  2024cites this paper